Leader Board Alert: Chelsea Therapeutics (NASDAQ: CHTP) is Up as Much as 69.29% Intraday on Friday

Chelsea Therapeutics (NASDAQ: CHTP) is on The StockGuru Leader Board today.  The stock is up as much as 69.29% on Friday.

Volume traded – so far – as this release was issued intraday:  17,866,812

Join in on the Discussion about CHTPhttp://members.stockguru.com/stocks/chtp/

About the Company:

Chelsea Therapeutics International, Ltd., a development-stage pharmaceutical company,
focuses on the acquisition, development, and commercialization of therapeutic products for
the treatment of various human diseases. It is involved in developing Droxidopa, a
therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH)
associated with primary autonomic failure and falls related to NOH in Parkinson’s Disease
(PD), as well as other norepinephrine-related conditions and diseases, including intradialytic
hypotension, fibromyalgia, adult attention deficit hyperactivity disorder, chronic fatigue
syndrome, and freezing of gait in PD and down syndrome. The company intends to market its
Droxidopa drug under the Northera brand name. It also engages in developing a portfolio of
molecules for the treatment of various autoimmune/inflammatory diseases, including
rheumatoid arthritis, psoriasis, Crohn’s disease, ankylosing spondylitis, uveitis, psoriatic
arthritis, inflammatory bowel disease, cancer, and other immunological disorders. The
company’s molecule products include a portfolio of metabolically inert antifolate molecules
consisting of CH-1504 and CH-4051, which are orally available molecules with
anti-inflammatory, autoimmune, and anti-tumor properties that inhibit various key enzymes
required for cell proliferation; and a portfolio of dihydroorotate dehydrogenase, known as the
I-3D portfolio, for applications in autoimmune diseases and transplantation. Chelsea
Therapeutics International, Ltd. was founded in 2002 and is headquartered in Charlotte, North
Carolina.

About the StockGuru Leader Board:

We watch for stocks moving up and creating a positive momentum in the market.  We are not compensated for coverage.

Feel free to suggest a stock for coverage if you see it breaking out.  Contact: publisher@stockguru.com.

StockGuru.com
StockGuruCanada.com
Shareholdervision.com
BoldStocks.com
IR Affiliates – IRIR.co
StoneBridge Web & SEO – StonebridgeIQ.com

All content on StockGuru.com is original content – with the exception of client news releases. All content is (C) Copyright 2002 to 2012 StockGuru. No content may be used in whole or in part without the express written consent of our Publisher. We encourage web sites interested in our content to offer a reciprocal exchange agreement in exchange for use of some of our content. We do not offer advance approval, but contact our Publisher if you have an interest in repropagating our content. Contact as at: Publisher@StockGuru.com or (469) 252-3030. Mailing address: 1601 Berwick Drive; McKinney, Texas 75070